At the pulse of heart disease

We are pioneers in the discovery and development of non-coding RNA-based therapeutics designed to address the root causes of heart disease.

We leverage our deep RNA biology expertise to enable a paradigm shift in the treatment of heart disease

We are advancing transformative treatments to change the lives of millions of patients with different heart diseases

AHA Scientific Sessions

Event · November 11–13, 2023 · Philadelphia PA, USA

23rd Annual Biotech in Europe Forum

Event · September 20–21, 2023 · Basel, Switzerland

HF-REVERT Investigator Meeting 2023

Event · September 14–15, 2023 · Prague, Czech Republic